To view this email as a web page, click here.
 
PHARMACISTS' REPORT
 
New Drug Review: Pretomanid for Highly Drug Resistant Tuberculosis
image description here Indicated as part of a three-drug oral combination.

More
 
Oncology Market Remains Robust, Says Report
image description here The 2018 oncology drug market had a record number of new treatments and continued a trend of growth.

More
 
FDA Warns of NDMA Traces in Ranitidine Products
image description here Patients are still allowed to take medicines as prescribed.

More
 
ADVERTISEMENT
Learn about CPESN® and PrimeRx™ eCare Plan Initiative
PrimeRx users have come to realize the simplicity of the pharmacy management system in developing and maintaining their pharmacy eCare plans. Download whitepaper to read more about the PrimeRx eCare plan functionality! Learn more.
 
Read More
 
Major Chains to Dominate Expanding CBD Market
3 Tips for Incorporating Adverse Drug Reaction Reporting into Your Practice
FDA Issues Warning to CBD Product Suppliers
American Heart Association: Type 2 Diabetes Melllitutes a Risk Factor for Heart Failure
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.